Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials (Q34218132)
scientific article
Language:
Current Data About Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials
(P31) (Q13442814)
(P248)
(P698) 11301370
(P813) Monday, July 31, 2017

(P304) 13-19
(P248)
(P698) 11301370
(P813) Monday, July 31, 2017

(P433) 1 Suppl 3
(P248)
(P698) 11301370
(P813) Monday, July 31, 2017

(P478) 28
(P248)
(P698) 11301370
(P813) Monday, July 31, 2017

(P577) Thursday, February 1, 2001
(P248)
(P698) 11301370
(P813) Monday, July 31, 2017

(P921) (Q412616)
(P887)

(Q128581)
(P887)

(P1433) (Q14330412)
(P248)
(P698) 11301370
(P813) Monday, July 31, 2017

(P1476) "Rationale for trastuzumab (Herceptin) in adjuvant breast cancer trials" (language: en)
(P248)
(P698) 11301370
(P813) Monday, July 31, 2017

(P2093) D Slamon
(P1545) 1
(P248)
(P698) 11301370
(P813) Monday, July 31, 2017

M Pegram
(P1545) 2
(P248)
(P698) 11301370
(P813) Monday, July 31, 2017

(P13046) (Q7318358)
(P248)

other details
description scientific article

External Links
(P356) 10.1016/S0093-7754(01)90188-5
(P698) 11301370